Delve Bio: Jim Stuart, Jay Wohlgemuth

Delve Bio, an infectious disease diagnostics firm that uses metagenomic sequencing, has appointed Jim Stuart as chief commercial officer and Jay Wohlgemuth as a company director.

Stuart joins the company from Invitae, where he was senior VP of commercial. Prior to that, he was sales director at Caris Life Science and director of diagnostic sales at Ambry Genetics. Wohlgemuth is managing partner at Trusted Health Advisors. Before that, he was chief medical officer and senior VP of research and development for medical and population health at Quest Diagnostics. Prior to that, he was director of clinical diagnostics, immunology, and tissue growth and repair at Genentech.